Characterization of early phases of cardiomyopathy syndrome pathogenesis in Atlantic salmon ( Salmo salar L.) through various diagnostic methods

• Published in: Journal of Fish Diseases
• Main Authors: Fritsvold, Camilla, Mikalsen, Aase B., Haugland, Øyvind, Tartor, Haitham, Sindre, Hilde
• Format: Article in Journal/Newspaper
• Language: English
• Published: Wiley 2022
• Subjects: Atlantic salmon; Salmo salar
• Online Access: http://dx.doi.org/10.1111/jfd.13659; https://onlinelibrary.wiley.com/doi/pdf/10.1111/jfd.13659; https://onlinelibrary.wiley.com/doi/full-xml/10.1111/jfd.13659

Abstract Since the first description of cardiomyopathy syndrome (CMS) in Atlantic salmon, in 1985, the disease caused by piscine myocarditisvirus (PMCV) has become a common problem in Atlantic salmon farming, not only in Norway, but also in other salmon farming countries like Scotland and Ireland. In the last years, CMS has been ranked as the most important salmon viral disease in Norway regarding both mortality and economic losses. Detailed knowledge of infection and pathogenesis is still lacking, a decade after the causal agent was first described, and there is a need for a wider range of methods/tools for diagnostic and research purposes. In this study, we compared the detection of PMCV‐ and CMS‐related tissue lesions using previously used and well‐known methods like histopathology and real‐time RT‐PCR to immunohistochemistry (IHC), a less used method, and a new method, RNAscope in situ hybridization. Tissue samples of three different cardiac compartments, mid‐kidney and skin/muscle tissue were compared with non‐lethal parallel samplings of blood and mucus. The development of pathological cardiac lesions observed in this experiment was in accordance with previous descriptions of CMS. Our results indicate a viremic phase 10‐ to 20‐day post‐challenge (dpc) preceding the cardiac lesions. In this early phase, virus could also be detected in relatively high amount in mid‐kidney by real‐time RT‐PCR. Plasma and/or mid‐kidney samples may, therefore, be candidates to screen for early‐phase PMCV infection. The RNAscope in situ hybridization method showed higher sensitivity and robustness compared with the immunohistochemistry and may be a valuable support to histopathology in CMS diagnostics, especially in cases of untypical lesions or mixed infections.